SecBot SecBot
8-K ·Filed Oct 13, 2026

BLCO

Bausch & Lomb Corp
MIXED
Impact 6/10
Horizonweeks Processed13d 17h ago SEC0000950103-26-015460
8-K context-dependent: Items 5.02, 7.01
Actionable Insight ◆ Mixed

The CEO departure with a $75.5M severance and full equity forfeiture suggests a clean break, not a dispute. The guidance raise announcement ahead of Q3 earnings (Oct 28) is a positive signal on underlying business momentum. Watch for the magnitude of the guidance raise and Q3 results on Oct 28 to gauge whether the operational strength is broad-based.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+5d
BLCO ▲ +7.08% at T+5d
NEUTRAL call +7.08% · α vs SPY +8.24% · entry $15.81 → $16.93
Next anchor: T+20d in 14d
Latest observation: T+8 +11.83% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
+1.45%
call +1.45% · α +2.54%
$16.04
settled 13d ago
T+5d
+7.08%
call +7.08% · α +8.24%
$16.93
settled 7d ago
T+20d
Pending
in 14d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Bausch + Lomb CEO Brent Saunders has mutually agreed to depart, effective immediately, with Chairman Thomas Appio appointed as interim CEO. The company expects to raise full-year 2026 adjusted EBITDA guidance based on strong preliminary Q3 results. Saunders receives a $75.5 million cash severance and forfeits all outstanding equity awards.

Key Facts

  • CEO Brent Saunders and the Board mutually agreed on his departure, effective October 12, 2026; no dispute or disagreement cited.
  • Chairman Thomas J. Appio appointed interim CEO; Appio also serves as CEO of parent Bausch Health (BHC).
  • Saunders receives $75.5 million lump-sum cash severance plus up to $50,000 in attorneys' fees.
  • All of Saunders' outstanding equity awards (RSUs, PSUs, LPSUs, MSUs, stock options, New Hire Grants) were forfeited and cancelled for no additional consideration.
  • Company expects to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D guidance, citing continued strong Q3 business performance.
  • Full Q3 results and updated guidance details to be provided on October 28, 2026.
  • Saunders remains subject to existing restrictive covenants (confidentiality, non-competition, non-solicitation, non-disparagement).
  • Saunders will provide up to 90 days of transition assistance without additional compensation.

Financial Impact

$75.5 million cash severance payment to departing CEO; all outstanding equity awards forfeited (value not disclosed). Full-year 2026 adjusted EBITDA guidance expected to be raised — magnitude not specified.

cashadjusted EBITDAequity compensation

Risk Factors

  • Interim CEO Appio is also CEO of parent Bausch Health, raising potential governance and conflict-of-interest concerns.
  • The $75.5M cash severance is a material cash outflow with no disclosed offsetting savings.
  • Guidance raise is preliminary and unaudited; actual Q3 results may differ materially.
  • Loss of CEO Saunders could create leadership vacuum and execution risk during transition.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000950103-26-015460
Document: dp254863_ex9901.htm0000950103-26-015460
Document: dp254863_8k.htm0000950103-26-015460
Document: 0000950103-26-015460-index-headers.html0000950103-26-015460
Document: 0000950103-26-015460-index.html0000950103-26-015460
Document: 0000950103-26-015460.txt0000950103-26-015460
19 reports for BLCO
Performance horizon
100% Hit rate @ T+1 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +7.59%Jul 29, 2026
Filters
Rows
Reports for BLCO — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
8-K
MIXED ★ 6/10
$15.81 $16.04▲ +1.45%▲ +2.54%$17.58 (+11.20%)
Oct 1, 2026
26d ago
Court Ruling
BULLISH ★ 4/10
$17.11 $17.17▲ +0.35%▼ −0.32%$17.58 (+2.75%)
Sep 28, 2026
28d ago
144
NEUTRAL ★ 2/10
$16.95 $17.14▲ +1.12%▲ +1.31%$17.58 (+3.72%)
Aug 14, 2026
10w ago
3 / CLUSTER
NEUTRAL ★ 2/10
$17.00 $17.04▲ +0.24%▲ +0.91%$17.58 (+3.41%)
Aug 14, 2026
10w ago
3
NEUTRAL ★ 2/10
$17.00 $17.04▲ +0.24%▲ +0.91%$17.58 (+3.41%)
Aug 14, 2026
10w ago
3
NEUTRAL ★ 2/10
$17.00 $17.04▲ +0.24%▲ +0.91%$17.58 (+3.41%)
Aug 12, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$16.98 $17.05▲ +0.41%▲ +0.61%$17.58 (+3.53%)
Aug 12, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$16.98 $17.05▲ +0.41%▲ +0.61%$17.58 (+3.53%)
Aug 7, 2026
11w ago
144
NEUTRAL ★ 2/10
$16.83 $16.87▲ +0.24%▲ +0.56%$17.58 (+4.46%)
Aug 6, 2026
11w ago
144
NEUTRAL ★ 2/10
$16.35 $16.78▲ +2.63%▲ +2.02%$17.58 (+7.52%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (10h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026